Lung Ultrasound Versus Cardiometry in Detection of Extravascular Lung Water in Pediatric Patients on Hemodialysis.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Sara Mabrouk Mohamed Elghoul, MD
- Phone Number: 01099204120
- Email: saramabrouk888@yahoo.com
Study Locations
-
-
-
Tanta, Egypt
- Sara Mabrouk Mohamed Elghoul
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
50 children and adolescents with end stage renal disease on regular hemodialysis for three times weekly at TUH during the period of the study.
Inclusion criteria: Pediatric patients with end stage renal disease aged from 5 to 18 years on regular hemodialysis.
Exclusion criteria:
- Patients with coexisting lung fibrosis, atelectasis, and interstitial lung disease.
- Patients with heart failure.
- Patients with implantable cardiac pacemaker or defibrillator.
Description
Inclusion Criteria:
- Pediatric patients with end stage renal disease aged from 5 to 18 years on regular hemodialysis
Exclusion Criteria:
- Patients with coexisting lung fibrosis, atelectasis, and interstitial lung disease.
- Patients with heart failure.
- Patients with implantable cardiac pacemaker or defibrillator
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
50 children and adolescents with end stage renal disease on regular hemodialysis
50 children and adolescents with end stage renal disease on regular hemodialysis for three times weekly
|
: B-lines of lung ultrasound and the parameters of cardiometry will be measured at the mid-week HD session before starting the session by 30 min then every 30min during HD session for 180 min and then after the end of the session of HD by 30 min and then The specificity and sensitivity of both techniques will be compared to each other
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
volume status in pediatric patients on regular hemodialysis
Time Frame: six months
|
detection of the fluid status in pediatric patients on regular hemodialysis
|
six months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Sara Mabrouk Mohamed Elghoul, MD, Tanta University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 36264PR187/4/23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.